Bill Commons

MD SB 785

withdrawn

Public Health and Health Insurance - Access to Abortion Care - Reporting Requirements

Maryland · 2026 Regular Session · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did MD SB 785 pass?

No. MD SB 785 was withdrawn and is no longer under consideration. Latest recorded action (2026-03-16): Withdrawn by Sponsor

What is MD SB 785 about?

MD SB 785 is a bill in the 2026 Regular Session titled “Public Health and Health Insurance - Access to Abortion Care - Reporting Requirements”.

Who sponsors MD SB 785?

Guzzone is the primary sponsor of MD SB 785.

Introduced
—
Latest action
2026-03-16 — Withdrawn by Sponsor
Bill type
bill
Last updated
—

Sponsors

  • Guzzoneprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-03-16

    Withdrawn by Sponsor

    withdrawal

  2. 2026-03-05

    Hearing canceled

  3. 2026-03-04

    Hearing 3/12 at 1:00 p.m.

  4. 2026-03-04

    Hearing canceled

  5. 2026-02-12

    Hearing 3/10 at 1:00 p.m.

  6. 2026-02-06

    First Reading Finance

    referral-committee

Versions

  • First - Public Health and Health Insurance - Access to Abortion Care - Reporting RequirementsCompare

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:23:32.621655Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MD&identifier=SB 785. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.